For the past 15 years, the Drug Information Association (DIA) China Annual Meeting has become the most-attended conference for professionals working in the drug development life cycle, from discovery to marketed use in Asia.

Why you should participate

The DIA 2025 attracted more than 5,000 life cycle drug development professionals from NMC & local pharma companies, clinical study sites and CROs/CDMOs of over 30 countries and regions, and over 300 exhibitors globally.

• China’s demographic shifts, aging population and rising middle class are driving increased healthcare spending and demand for innovative therapies.
• Strong central government support, major investments, and a commitment to technological progress, China’s Biotech and MedTech sectors have grown significantly over the last decade, making it a major player in global biotech and MedTech.
• Over the past five years, China has transitioned to a central pillar of global innovation.
• Chinese companies are involved in one-fifth of pharma’s clinical development programs, second behind the United States.
• The program will also offer participants an opportunity to explore dynamism in west China by including an outreach program to Chengdu, an emerging biotech and medtech hub in China.

If you are interested in participating, please register by 11.00 pm AEDT, Sunday 22 March.

Australian Clinical Trials Initiative (ACTI)

The Austrade mission to DIA China-Chengdu 2026 is delivered as part of the broader Australian Clinical Trials Initiative (ACTI) ecosystem. ACTI is a coordinated, national effort to promote Australia as an attractive clinical trials destination. ACTI will encompass 25 events over 18 months, taking place across Europe, North America, the Middle East and Africa (MENA), and Asia-Pacific (APAC).

Go to the ACTI homepage to learn more.


Please register your interest in attending DIA China - Chengdu 2026. Austrade will evaluate all registrations submitted and we will reach out to you to confirm your eligibility, as well as provide information on the next steps and confirmation of participation.